The annual diagnosis of new breast cancer cases stands at 6000 cases in Kenya, which could hypothetically imply that the extent of BRCA1 and BRCA2 mutation is higher in our population and goes undetected due to lack of screening. The gene discussed is BRCA2; the disease is breast cancer.